Lowell Therapeutics Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
3
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$32.5M
Lowell Therapeutics General Information
Description
Developer of FDA-approved smart devices designed for the treatment of acute kidney disease. The company provides regional anticoagulants for patients with sudden kidney failure in the ICU who need to go on an artificial kidney machine for dialysis around the clock, which is called continuous renal replacement therapy, CRRT, enabling doctors and patients to experience less blood loss, fewer filter changes, and lower cost of doctor and nursing time.
Contact Information
Website
ltx.lifeCorporate Office
- 110 Canal Street
- Lowell, MA 01852
- United States
Corporate Office
- 110 Canal Street
- Lowell, MA 01852
- United States
Lowell Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 10-Jan-2022 | $32.5M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series B) | 01-Oct-2021 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 24-Mar-2020 | $50K | $50K | Completed | Generating Revenue |
Lowell Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A | 400,000 | $0.000100 | $2.5 | $2.5 | 1x | $2.5 | 4.7% |
Lowell Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lowell Therapeutics Patents
Lowell Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4157332-A1 | Methods of treating viral infection using protease inhibitors | Inactive | 26-May-2020 | ||
| EP-4157332-A4 | Methods of treating viral infection using protease inhibitors | Inactive | 26-May-2020 | ||
| US-20210369665-A1 | Methods of treating viral infection using protease inhibitors | Inactive | 26-May-2020 | ||
| WO-2021242760-A1 | Methods of treating viral infection using protease inhibitors | Inactive | 26-May-2020 | A61K31/245 |
Lowell Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lowell Therapeutics Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| K2X | Venture Capital | Minority | ||
| Securitas Biosciences Group | Holding Company | Minority | ||
| eCoast Angels | Angel Group | Minority |
Lowell Therapeutics FAQs
-
When was Lowell Therapeutics founded?
Lowell Therapeutics was founded in 2018.
-
Where is Lowell Therapeutics headquartered?
Lowell Therapeutics is headquartered in Lowell, MA.
-
What is the size of Lowell Therapeutics?
Lowell Therapeutics has 3 total employees.
-
What industry is Lowell Therapeutics in?
Lowell Therapeutics’s primary industry is Other Devices and Supplies.
-
Is Lowell Therapeutics a private or public company?
Lowell Therapeutics is a Private company.
-
What is the current valuation of Lowell Therapeutics?
The current valuation of Lowell Therapeutics is .
-
What is Lowell Therapeutics’s current revenue?
The current revenue for Lowell Therapeutics is .
-
How much funding has Lowell Therapeutics raised over time?
Lowell Therapeutics has raised $4.1M.
-
Who are Lowell Therapeutics’s investors?
K2X, Securitas Biosciences Group, and eCoast Angels have invested in Lowell Therapeutics.
-
When was Lowell Therapeutics acquired?
Lowell Therapeutics was acquired on 10-Jan-2022.
-
Who acquired Lowell Therapeutics?
Lowell Therapeutics was acquired by Talphera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
